Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting From Combined Use of Nestorone® Gel (0, 8 or 12 mg NES) and Testosterone Gel (10 g) Compared With Testosterone Gel in Normal Men
Conditions
Interventions
Testosterone
Nestorone®
+2 more
Locations
2
United States
Los Angeles Biomedical Research Institute at Harbor-UCLA
Torrance, California, United States
University of Washington
Seattle, Washington, United States
Start Date
May 1, 2009
Primary Completion Date
May 1, 2010
Completion Date
November 1, 2011
Last Updated
May 24, 2018
NCT06345586
NCT07115849
NCT06672016
NCT07365904
NCT07320651
NCT06334315
Lead Sponsor
Premier Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions